Research Article
Application of Eudragit RS 30D as a Potential Drug Release Retardant of Acetaminophen and Caffeine for Prolonged Duration of Comfort
Table 3
Evaluation of postcompression parameters of formulation EF1-EF3.
| Formulation | Weight variation (mg (±SD)) () | Hardness (KG (±SD)) () | Thickness (mm (±SD)) () | Diameter (mm (±SD)) () | Friability (%) () | Assay (%) () |
| EF1 | 1288.05 (±5.698) | 7.19 (±0.09) | 8.85 (±0.006) | 19.41 (±0.01) | 0.46 | 100.43 (±0.756) | EF2 | 1300.7 (±5.63) | 7.29 (±0.055) | 8.88 (±0.004) | 19.41 (±0.004) | 0.46 | 104.53 (±0.252) | EF3 | 1350.7 (±3.278) | 7.43 (±0.044) | 8.89 (±0.007) | 19.41 (±0.006) | 0.96 | 98.32 (±0.395) |
|
|